- The Food and Drug Administration has approved Akebia Therapeutics’ blood-boosting pill Vafseo for people with anemia from chronic kidney disease, the company said Wednesday, reversing a rejection the agency made two years ago over the drug’s safety.
- The decision came after a review of safety data from Japan,…
Click here to view original postClick Here to Publish/Feature Your Company or Product News with Biotech Networks
